# ANti-Oxidant in Variant Angina (ANOVA) Trial

Study · id `cardio:ct-nct03228238` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03228238](<https://clinicaltrials.gov/study/NCT03228238>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03228238

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 320 participants.

## Technical summary

Registry record NCT03228238. Randomized; no masking; primary purpose treatment. Start 2014-09-01 (actual); primary completion 2024-06-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 320 participants (enrolled count; ClinicalTrials.gov record NCT03228238, source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)
- Started: 2014-09-01 (actual) (ClinicalTrials.gov record NCT03228238, source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)
- Primary completion: 2024-06-01 (actual) (ClinicalTrials.gov record NCT03228238, source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)
- Completion: 2024-06-01 (actual) (ClinicalTrials.gov record NCT03228238, source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT03228238, source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03228238-2026-04-27`, retrieved 2026-11-18)

## The registry's words

- Brief title: ANti-Oxidant in Variant Angina (ANOVA) Trial
- Condition: Variant Angina
- Intervention (Drug): Vitamin C and Vitamin E
- Intervention (Drug): Statin
- Intervention (Drug): Standard medication for variant angina
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Microvascular and vasospastic angina (`cardio:microvascular-and-vasospastic-angina`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)

## Provenance

Content hash: 9e19f9a18cd8d3babc49f5f1f60f88ae1f68c2539c77ed2c718a6517e6efe9b7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
